Group 1 - The Shanghai Stock Exchange held a special meeting to promote the "1+6" policy for the Sci-Tech Innovation Board, aiming to enhance the coordination between investment and financing in the capital market [1] - Over 100 representatives from more than 20 market institutions, including public funds, securities companies, and insurance asset management, attended the meeting, showing strong support for the series of reform measures [1] - The Sci-Tech Innovation Board has become the segment with the highest proportion of index investment in A-shares, with the free-floating market value proportion reaching 8.3% [1] Group 2 - The "1+6" policy framework is expected to provide new opportunities for index investment in the Sci-Tech Innovation Board, injecting lasting momentum into the market's healthy and stable development [2] - The Shanghai Stock Exchange plans to enhance communication with market participants and implement relevant policy deployments to support innovation-driven development [2] - The number of Sci-Tech Innovation Board ETFs has nearly doubled since the release of the "Eight Measures," with a total of 85 ETFs listed and a total scale exceeding 250 billion yuan, reflecting a growth of over 60% [1][2]

Group 1 - The pharmaceutical sector has led the market with a 50.88% increase in the Hang Seng Healthcare Index this year, driven by innovative drugs and CXO services [1] - Three main drivers are contributing to the industry's value reassessment: policy benefits, technological breakthroughs, and capital inflow [1] - The E Fund Pharmaceutical ETF Connect Fund has achieved a 15.29% return over the past year, outperforming the CSI 300 Index, with a fund size exceeding 20.6 billion yuan [1] Group 2 - The current pharmaceutical industry is supported by both policy and demand, with improved negotiation rules for medical insurance and a solid growth in medical spending due to aging and consumption upgrades [1] - Core assets like WuXi AppTec and Mindray Medical are still recognized despite short-term pressures, with 15 out of 18 institutions giving a "buy" rating to Kelun Pharmaceutical [1] - The E Fund Pharmaceutical ETF Connect C has shown strong defensive characteristics, with a 6.58% return over the past three months, outperforming the 300 Pharmaceutical Index [1] Group 3 - The E Fund Pharmaceutical ETF Connect Fund offers a cost-effective way for investors to access leading pharmaceutical companies, with a current PE ratio of 28.61, below the five-year average [2] - The fund's management fee is only 0.5%, significantly lower than the typical 1.5% for actively managed pharmaceutical funds, making it attractive for investors [2] - A "pyramid-style" accumulation strategy is recommended for investors, with short-term traders focusing on the C share class and long-term investors on the A share class [2]

Group 1 - The core viewpoint of the article highlights the increasing importance of ETFs as liquidity management tools and asset allocation vehicles amid the ongoing recovery of the domestic economy and the diversification of asset allocation needs [1][6] - The Shenzhen Stock Exchange (SZSE) is actively promoting ETF market development through educational activities and product innovation, aiming to foster a favorable market ecosystem for ETFs [3][6] - The ETF market in China is experiencing significant growth, with an expanding product system and improving market liquidity, presenting important development opportunities [4][6] Group 2 - Experts from SZSE and representatives from Western Securities and E Fund emphasized the importance of rational, value, and long-term investment philosophies during the recent events [3] - E Fund's strategy focuses on low fees, refined management, and enhancing service capabilities, with plans to further develop the "ETF toolbox" to meet the needs of the real economy and investors [3][4] - The event attracted over 300 investors, indicating strong interest in ETF investment strategies and the ongoing economic recovery [4]

1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints of the Report - The scale of Huatai-PineBridge CSI A500 ETF has rapidly increased, and its extended securities abbreviation has changed. It has become the leader in the CSI A500 ETF track in terms of scale [1][8]. - Multiple index products are in the process of being established, raised, and declared. There are new offerings of many science and technology innovation bond ETFs, and three companies, including Huatai-PineBridge, have declared aviation-themed ETFs [2][14][23]. - In the recent week, most A-share and US stock ETFs have risen, with the Innovation Drug ETF leading the gains. The CSI Bank ETF has the largest net inflow of funds, while the CSI 300 ETF has the largest net outflow [5][26][43]. 3. Summary According to the Table of Contents 3.1 Huatai-PineBridge CSI A500ETF Scale Rapidly Increases, and the Extended Securities Abbreviation Changes Recently - Huatai-PineBridge CSI A500ETF (563360.OF) has performed well recently. Its scale has rapidly increased from less than 10 billion yuan to about 20 billion yuan in the past month. As of July 6, its scale reached 19.957 billion yuan, surpassing competitors and ranking first in the CSI A500ETF track [1][8]. - Since July 3, 2025, the extended abbreviation of Huatai-PineBridge CSI A500ETF has changed from "CSI A500ETF Fund" to "A500ETF Huatai-PineBridge", which strengthens brand recognition and improves trading convenience [12][13]. 3.2 Index Product Establishment, Raising, and Declaration: Multiple Science and Technology Innovation Bond ETFs are Being Raised and Newly Issued, and Three Companies, Including Huatai-PineBridge, Declare Aviation-Themed ETFs 3.2.1 Product Establishment and Listing Situation - In the recent week, 11 products, such as Southern CSI Hong Kong Stock Connect Technology ETF, have been established; 10 products, such as Penghua CSI All-Share Free Cash Flow ETF, have been listed; and 7 products, such as Qianhai Kaiyuan CSI 500 Equal-Weighted Linked A, have completed fundraising and are about to be established [2][14]. 3.2.2 Product Issuance Information - In the coming week, 24 index products will end their fundraising, including Huatai-PineBridge CSI A500ETF, Huabao Shanghai Stock Exchange STAR Market Artificial Intelligence Linked A, and Fuguo CSI AAA Science and Technology Innovation Corporate Bond ETF. Meanwhile, 28 products will start their fundraising, including Fuguo CSI AAA Science and Technology Innovation Corporate Bond ETF, GF Shanghai Stock Exchange AAA Science and Technology Innovation Corporate Bond ETF, and Boshi Shanghai Stock Exchange AAA Science and Technology Innovation Bond ETF [2][18]. 3.2.3 Product Declaration Information - In the recent week, a total of 17 index products have been declared. The theme products include Huatai-PineBridge CSI General Aviation Themed ETF and Ping An CSI General Aviation Themed ETF; the index enhancement products include Tianhong CSI 500 Quantitative Index Enhancement Securities Investment Fund and Jinyuan Shun'an CSI 800 Index Enhancement Securities Investment Fund; there are also 5 linked products and 2 bond products [23]. 3.3 ETF Market Review: Innovation Drug ETF Leads the Gains - In the recent week, most A-share and US stock ETFs have risen. Among A-share ETFs, ChiNext 50ETF has the highest increase of 1.91%, and MSCI China A50ETF and CSI 300ETF have relatively high increases of 1.72% and 1.64% respectively. Among US stock ETFs, S&P 500ETF has a relatively high increase of 1.63%. All Hong Kong stock ETFs have declined, with Hang Seng Technology ETF and Hang Seng Internet ETF having relatively large declines of -2.54% and -2.43% respectively [26]. - Among commodity ETFs, the gold ETF has a relatively high increase of 1.11% in the recent week, while the energy and chemical ETF has a slight decline. Most industry ETFs have risen in the recent week. All medical ETFs have increased, with the Innovation Drug ETF having the highest increase of 4.74%. Among other sub - industries, the Steel ETF has the leading increase of 5.53%, and the Photovoltaic ETF and Bank ETF have relatively high increases of 4.42% and 3.76% respectively [26][29]. 3.4 ETF Fund Flow: CSI Bank Has the Largest Net Inflow - As of July 4, 2025, there are 1,247 ETFs in the entire market, with a total scale of 4,317.864 billion yuan, an increase of 41.175 billion yuan from the previous week. Among them, A-share ETFs and cross - border ETFs rank first and second in scale, with 3,012.54 billion yuan and 585.014 billion yuan respectively. The scale of A-share ETFs has increased by 14.535 billion yuan in the recent week [41]. - Among non - monetary ETFs, the ETFs targeting the CSI Bank have the largest net inflow of funds, with an inflow of 6.38 billion yuan, while the ETFs targeting the CSI 300 have the largest net outflow of funds, with a total outflow of 11.181 billion yuan [43]. - In the recent week, Huabao CSI Bank ETF and E Fund Shanghai Stock Exchange Benchmark Market - Making Corporate Bond ETF have relatively high fund inflows, with 6.084 billion yuan and 1.982 billion yuan respectively. Haifutong CSI Short - Term Financing ETF has the leading liquidity in the recent week, with an average daily trading volume of 14.2 billion yuan. Southern Shanghai Stock Exchange Benchmark Market - Making Corporate Bond ETF has relatively high liquidity, with an average daily trading volume of 12.652 billion yuan [47].

Core Viewpoint - Index investment has become a focal point in the public fund industry amid deepening capital market reforms and accelerated transformations in the industry [1] Group 1: Industry Trends - The China Securities Regulatory Commission (CSRC) released the "Action Plan for Promoting High-Quality Development of Public Funds" in May, aiming to shift the industry focus from "scale" to "returns" through systematic reforms [1] - The plan includes measures to bind the interests of fund managers and investors, improve assessment mechanisms, and increase the scale and proportion of equity investments in public funds, addressing industry pain points [1][2] - The emphasis on long-term performance assessment and the constraints of performance benchmarks are particularly noteworthy [1] Group 2: Investment Strategies - Investment strategies that are close to benchmarks, stable in style, and yield steady excess returns are expected to thrive as the plan progresses [2] - Index-enhanced funds, which aim to achieve excess returns relative to benchmarks while effectively tracking them, align well with the industry's transformation direction and are likely to attract more capital [2] - Data shows that over the past five years, index-enhanced funds have had significantly lower tracking errors compared to actively managed equity funds, leading to a better overall experience for investors [2] Group 3: Role of Quantitative Investment - Quantitative investment plays a crucial role in index investment by utilizing systematic and scientific methodologies [2] - Quantitative strategies help fund managers control tracking errors more precisely and capture excess returns from market pricing discrepancies [2] - The combination of fundamental quantitative strategies and data-driven approaches enhances research depth and diversifies returns [3] Group 4: Challenges and Recommendations - Historically, index-enhanced funds have had a low market share in public equity funds due to challenges such as being perceived as difficult to understand or unattractive [3] - Fund managers need to actively promote quantitative methodologies to help investors comprehend their value [3] - For ordinary investors, a dollar-cost averaging approach is recommended to smooth out market volatility, with an emphasis on risk diversification [3] Group 5: Future Outlook - The integration of quantitative strategies and index investment reflects not only technological innovation but also a return to the industry's core focus on investor interests [4] - The company aims to deepen its engagement in quantitative investment to create sustainable returns for investors and contribute to the optimization of financial resource allocation [4]

Group 1 - The overall fund issuance market showed significant differentiation last week, with only 20 new funds established and a total issuance scale of 5.328 billion yuan, marking the lowest weekly fundraising since April this year [1] - The average fundraising per fund was only 266 million yuan, indicating a generally sluggish issuance market [1] Group 2 - Equity funds performed strongly, with 11 equity fund products raising 3.226 billion yuan, accounting for 60.54% of the total issuance, making them the main force in the week [3] - Passive index products were particularly notable, with 8 index funds collectively raising over 2 billion yuan, nearly half of the total issuance, focusing on popular sectors such as Hong Kong tech and core A-share assets [3] - The Southern CSI Hong Kong Stock Connect Technology ETF raised 705 million yuan, and the Morgan Stanley CSI 300 Free Cash Flow Link A raised 597 million yuan, reflecting institutional preference for index-based investments [3] Group 3 - Bond fund issuance cooled significantly, with only 3 bond fund products issued, totaling 1.067 billion yuan, accounting for 20.03% of the total, a stark contrast to previous strong performances [4] - Mixed fund issuance remained relatively stable, with 5 mixed fund products raising 3.226 billion yuan, accounting for 19.23%, with an average fundraising of 645 million yuan per fund [4] - Passive index funds emerged as the absolute mainstay of new fund issuance, with a rapid launch of the Huatai-PineBridge CSI Hong Kong Stock Connect Technology Link A, highlighting institutional intent to quickly position in the Hong Kong tech sector [4]

近日，首批10只科创债ETF（交易型开放式指数基金）正式获批，我国债券ETF产品谱系进一步丰富， 资本市场支持科技创新迎来新工具。 6月18日，中国证监会主席吴清在2025陆家嘴论坛上表示，大力发展科创债，优化发行、交易制度安 排，推动完善贴息、担保等配套机制，加快推出科创债ETF。同日，10家公募基金上报首批科创债 ETF。其中，易方达基金、广发基金、华夏基金、鹏华基金、博时基金、招商基金6家公募基金在上交 所上报，嘉实基金、南方基金、富国基金、景顺长城基金4家公募基金在深交所上报。7月2日，上述10 只科创债ETF正式获批。 此次科创债ETF的推出，将有效填补公募基金在"科技金融"债券基金领域的空白，助力科技强国建设。 同时，科创债ETF通过其高度聚焦的投资主题设计，吸引各类资金精准投向科创重点领域，为科创企业 拓宽融资来源、降低融资成本并提高融资效率。 "在债券市场'科技板'启航的背景下，科技创新债券发行主体扩容，由金融机构、科技型企业、股权投 资机构三类机构发行，所募集资金用于支持科技创新领域投融资。"易方达债券指数投资部总经理李一 硕表示，科创债自试点以来，发行不断提速，现正处于快速扩容阶段，募集资 ...

Group 1 - The overall market saw the establishment of 20 new funds last week, with a total issuance scale of only 5.328 billion yuan, marking the lowest weekly fundraising since April this year, with an average fundraising of only 266 million yuan per fund [1] - Despite the overall sluggish issuance market, there are structural highlights, with equity funds leading the way, accounting for 60.54% of the total issuance, reflecting institutional confidence in equity assets [1] - The issuance of bond funds has significantly cooled down, with only 3 products raising 1.067 billion yuan, a decline compared to previous strong performances [1] Group 2 - Passive index funds became the main force in new fund issuance last week, accounting for over 60%, with over 20 products launched covering popular sectors such as securities, technology, consumption, and pharmaceuticals [2] - Enhanced index funds are also favored by public fund managers, with several products launched to meet investors' demand for excess returns through quantitative strategies [2] - Although the overall scale of newly issued funds last week was limited, many institutions are preparing for the second half of the year, with multiple funds pending approval across various themes [2]

Group 1 - The private equity fund industry in China is experiencing a surge in product registrations, with 1,775 private securities investment fund managers completing 5,461 product registrations in the first half of 2025, representing a year-on-year increase of 53.61% and a more than 100% increase compared to the second half of the previous year, indicating a significant recovery in market confidence and an enhanced willingness for capital allocation [1] - Among the five primary strategies, the stock strategy leads with 3,458 registered products, accounting for 63.32% of the total, reflecting strong enthusiasm for equity asset allocation, driven by factors such as the release of technology innovation policy dividends and robust performance in key sectors like artificial intelligence [1] - Multi-asset strategies and futures and derivatives strategies follow with 802 and 633 registered products, representing 14.69% and 11.59% respectively, highlighting an increased demand for diversified allocation in a low-interest-rate environment [1] Group 2 - Quantitative private equity institutions have shown remarkable performance during the current registration wave, with 27 out of 33 institutions having at least 20 registered products being quantitative, including 18 large-scale institutions with over 10 billion yuan in assets, showcasing their advantages in research capabilities, risk control systems, and brand effects [2] - A total of 2,448 registered quantitative strategy private products were recorded, with stock quantitative strategies dominating at 1,715 products, accounting for 70.06%, and the index enhancement strategy being the most favored with 1,061 products, representing 61.87% of stock quantitative strategies [2] - The small and micro-cap sector is expected to become a blue ocean for excess returns in quantitative strategies, as traditional broad-based index strategies face intensified competition and diminishing excess returns due to increased capital inflow [3]

Core Viewpoint - The launch of the Jiashi CSI AAA Technology Innovation Company Bond ETF provides a convenient investment tool for participating in the technology innovation bond market, reflecting the growing importance of such financial products in supporting technological advancements and economic transformation [1][2]. Group 1: Product Overview - Jiashi CSI AAA Technology Innovation Company Bond ETF tracks the CSI AAA Technology Innovation Company Bond Index, which includes bonds rated AAA and above from high-quality technology companies, primarily state-owned enterprises and reputable private firms [2]. - The index has shown strong historical performance, with returns of 5.5%, 6.0%, and 3.81% for 2023, 2024, and the past year, respectively [2]. Group 2: Investment Features - The ETF is designed to be a low-cost, efficient investment option for credit bonds, with management fees at 0.15% and custody fees at 0.05%, enhancing yield in a low-interest environment [4]. - It offers cash subscription/redemption, regular dividend assessments, and efficient trading features, making it accessible for both institutional and individual investors [3][4]. Group 3: Management Strategy - The investment strategy combines sampling replication and dynamic optimization to minimize tracking error, selecting highly liquid bonds from the index and its alternatives [5][6]. - The fund manager, Wang Zhe, has extensive experience in fixed income investment and employs risk-controlled active management strategies to seek excess returns [7][8]. Group 4: Future Outlook - The macroeconomic environment is expected to maintain low interest rates, supporting a bullish bond market, while the commercialization of technological breakthroughs may enhance the profitability of bond issuers, positively impacting ETF net value and long-term investor returns [9].